Recently, a new developmental pathway for CD4 T cells that is
Upon antigen stimulation, naive CD4 T cells can diff erentiate into Th1, Th2, or the newly characterized Th17 eff ector cells, which rapidly produce IFN-␥ , IL-4, or IL-17, respectively ( 1 -4 ) . The hallmark cytokine of Th1 cells is IFN-␥ , which is instrumental for cell-mediated immunity. Th2 cells produce the prototypical cytokine IL-4, as well as IL-5 and IL-13, in controlling humoral immune responses. IL-17, collectively with other cytokines and chemokines released by activated Th17 cells, plays an important role in several infl ammatory autoimmune diseases ( 5 -10 ) . Thus, proper regulation of Th diff erentiation is critical for controlling both cellular and humoral immune responses and for maintaining immune homeostasis.
The cytokines made by pathogen-activated cells of the innate immune system during T cell priming are key factors in promoting Th diff erentiation. It is known that type I or type II IFNs from activated NK cells or plasmacytoid DCs, collectively with IL-12 produced by APCs, direct CD4 T cells into the Th1 cell lineage. IL-4 present in the priming environment preferentially induces Th2 cell diff erentiation. TGF-␤ and IL-6 promote the development of Th17 cells that expand in response to IL-23 ( 11 -13 ) . The Th1 and Th2 cytokines IFN-␥ and IL-4, respectively, can inhibit the production of the opposing types of cytokines by CD4 T cells and antagonize Th17 cell diff erentiation. Th cell fate has also been shown to be infl uenced by several other factors including TCR affi nity, antigen dosage, co-stimulatory molecules, and the type of APC ( 14 -17 ) . However, it is not known whether T cell selection in the thymus aff ects Th cell fate in the periphery.
Recently, we and others have demonstrated that MHC class II -expressing thymocytes can effi ciently mediate the positive selection of CD4 T cells in mice ( 18, 19 ) . Human thymocytes express MHC class II, and thymocyte-mediated CD4 ously demonstrated that CD4 T cells can be positively selected via both cortical TECs (cTECs) and thymocytes ( 19 ) . Therefore, CIITA Tg mice generate a mixed population of CD4 T cells that are selected on TECs or thymocytes, whereas the control (WT) mice have only TEC-selected CD4 T cells ( 19 ) . To distinguish between the two CD4 T cell populations present in CIITA Tg mice, we named them E-and T-CD4 T cells to refl ect the cell type mediating selection (epithelial cell -and thymocyte-selected CD4 T cells, respectively).
To study whether CD4 T cell function is diff erent depending on their selection pathway, we initially examined the cytokine production potential of T-CD4 T cells upon in vivo stimulation. Although we have reported that CD4 T cells prepared from CIITA Tg mice produced elevated IL-4, the cytokine production upon in vivo stimulation was not studied ( 29 ) . WT and CIITA Tg mice were injected with an anti-CD3 antibody i.v., and the levels of serum IL-4 and IFN-␥ were measured 2 h later. CIITA Tg mice that have T-CD4 T cells showed a dramatic increase in both cytokines, suggesting an eff ector phenotype of T-CD4 cells ( Fig. 1 A ) . Consistent with the in vivo induction of IL-4 and IFN-␥ production, splenic CD4 T cells from CIITA Tg mice expressed more IFN-␥ and IL-4 than WT mice 5 h after stimulation in vitro ( Fig. 1 B ) ( 29 ) . Moreover, splenic CD4 T cells from CIITA Tg mice had a greater potential to produce IL-4 and IFN-␥ than WT mice after a 2-d stimulation in vitro ( Fig. 1 C ) .
T-CD4 Th1 cells produce Th2 cytokines in addition to IFN-␥ Next, we investigated the eff ector function of T-CD4 T cells in comparison to E-CD4 T cells. For this set of experiments, we included CIITA Tg /CIITA Ϫ / Ϫ mice that only generate T-CD4 T cells because of a defi ciency of MHC class II expression in TECs ( 19 ) . Because there are more peripheral CD4 T cells of the eff ector/memory type (CD44 hi CD45RB lo ) in CIITA Tg and CIITA Tg /CIITA Ϫ / Ϫ mice than in WT mice (i.e., 42 ± 9%, 41 ± 7%, and 27 ± 6% among splenic CD4 T cells, respectively; Fig. S1 B) , we sorted naive CD4 T cells (CD44 lo CD45RB hi )
T cell selection provides a mechanism for several documented observations that could not be otherwise explained ( 20 -28 ) . Therefore, in humans, CD4 T cells can be selected by two pathways, and the two CD4 T cell populations likely coexist in the periphery. Because mouse thymocytes do not express MHC class II, thymocyte-mediated selection has not been considered, and the role of this pathway in Th cell fate has been neglected.
We report in this study that thymocyte-selected CD4 (T-CD4) T cells diff er from thymic epithelial cell (TEC) -selected CD4 (E-CD4) T cells in that they can rapidly produce both IL-4 and IFN-␥ upon in vivo as well as in vitro TCR stimulation. When diff erentiated into eff ector cells under nonpolarizing conditions, these T-CD4 T cells appear to be Th0 eff ector cells able to produce both Th1 and Th2 cytokines. Furthermore, they maintained the capability to produce the opposite type of cytokines when diff erentiated into Th1 or Th2 cell lineages.
T-CD4 cells made IL-4 shortly after stimulation and also produced Th2 cytokines under Th1-inducing conditions in a Stat6-independent manner. A high level of preformed IL-4 mRNA were detected in CD4 single-positive (SP) thymocytes if they are selected on thymocytes, which is at least partly caused by enhanced histone acetylation of the IL-4 locus. Finally, T-CD4 T cells seem to have a protective role during an airway challenge, suggesting a unique regulatory function of T-CD4 T cells during an immune response.
RESULTS

T-CD4 T cells rapidly produce both IL-4 and IFN-␥
We generated mice that express MHC class II in thymocytes (Fig. S1 A, available at http://www.jem.org/cgi/content/full/ jem.20070321/DC1) and peripheral T cells by introducing the MHC class II transactivator (CIITA) as a transgene under control of the CD4 promoter (CIITA Tg ) ( 29 ) . CIITA is a transcription factor that is both necessary and suffi cient for the expression of molecules that participate in MHC class IIrestricted antigen presentation ( 30 ) . Using these mice, we previ- cytokine-producing CIITA Tg /CIITA Ϫ / Ϫ cells ( Fig. 2 B ) . Total CD4 T cells from the same mice showed a similar cytokine pattern as naive CD4 T cells (Fig. S3) . Other Th2 cytokines, such as IL-5 and IL-13, were also increased in CIITA Tg or CIITA Tg / CIITA Ϫ / Ϫ CD4 T cells (unpublished data) ( 29 ) . Because CIITA Tg and CIITA Tg /CIITA Ϫ / Ϫ CD4 T cells can express the opposite cytokines, even under Th1-or Th2-skewing conditions, and the Th1 cells expressed a relatively more prominent amount of IL-4, we subsequently focused on the characterization of Th2 cytokine production by T-CD4 Th1 cells.
The thymocyte-mediated T cell selection pathway is responsible for the phenotype of T-CD4 T cells
To further substantiate the role of the CD4 T cell selection pathway in cytokine production potential, we used BM chimeric mice. We previously showed that in the WT hosts (C57BL/6), CIITA Tg CD4 cells are developed on thymocytes as well as on cTECs, whereas in MHC class II -defi cient hosts, CD4 cells are only selected on thymocytes ( 19 ) . Using this principle, we generated and examined three types of chimeric from total peripheral CD4 T cells (Fig. S2 , available at http:// www.jem.org/cgi/content/full/jem.20070321/DC1). Sorted naive cells were then diff erentiated under neutral (ThN)-, Th1-, or Th2-inducing conditions. ThN cells from WT mice produced a small amount of IFN-␥ and almost undetectable levels of IL-4 ( Fig. 2, A and B ) . In contrast, CIITA Tg cells made a lot more IFN-␥ and IL-4 than WT cells. Moreover, CIITA Tg / CIITA Ϫ / Ϫ cells produced very high levels of both IFN-␥ and IL-4 ( Fig. 2, A and B ) . Th1 cells from WT mice predominantly made IFN-␥ but not IL-4, whereas both CIITA Tg and CII-TA Tg /CIITA Ϫ / Ϫ Th1 cells produced IL-4 in addition to IFN-␥ ( Fig. 2, A and B ) ( 29 ) Antigen presentation potential of TECs versus thymocytes dictates selection and the phenotype of the resulting CD4 T cells We previously reported that MHC class II I-E expressed as a transgene under the control of the MHC class I promoter (I-E Tg ; Fig. S1 A) can also mediate CD4 T cell selection in the absence of endogenous CIITA, albeit at a low effi ciency ( 19 ) . Interestingly, CD4 T cells in these mice (I-E Tg /CIITA Ϫ / Ϫ ) also showed a similar phenotype to that of CD4 T cells in CII-TA Tg mice ( Table I ) ( 31 ) . Surprisingly, however, the same I-E transgene on the A ␤ Ϫ / Ϫ background (I-E Tg /A ␤ Ϫ / Ϫ ) did not generate CD4 T cells that can produce IL-4 under Th1 cell diff erentiation conditions ( Table I ) ( 32 ) . In both types of I-E Tg mice, CD4 T cells are expected to be selected on thymocytes and, therefore, their phenotype should be similar. We wondered whether thymocytes and TECs in the two models have a diff erential potential to support CD4 T cell selection, which results in the diff erent phenotype of CD4 T cells. Unlike the MHC class II I-E transgene, CIITA also induces the expression of Ii and H-2M in cells, which allow them to become effi cient APCs ( 33, 34 ) . In fact, CIITA Tg thymocytes express high levels of both Ii and H-2M mRNA (unpublished data). Conversely, CIITA Ϫ / Ϫ cells express decreased Ii and H-2M ( 35 ) . Therefore, introducing the I-E transgene to CIITA Ϫ / Ϫ mice mice: WT → B6, CIITA Tg → B6, and CIITA Tg → CIITA Ϫ / Ϫ mice, which generate E-CD4, E-and T-CD4, and T-CD4 T cells, respectively. CD4 T cell reconstitution was comparable among all chimeras but was lacking in the control WT → CIITA Ϫ / Ϫ chimeric mice ( ( Fig. 3 A ) . In addition, the Th2 cell cultures from CIITA Tg → B6 and CIITA Tg → CIITA Ϫ / Ϫ chimeras that had T-CD4 T cells also produced greater numbers of IFN-␥ -expressing cells than WT → B6 mice, whereas IFN-␥ production by Th2 cells was variable among chimeras ( Fig. 3 A ) . This variability in cells producing IFN-␥ alone or IFN-␥ together with IL-4 in WT → B6 mice seems to correlate with cell activation caused by the lymphopenic environment of the hosts ( 19 ) because these two populations are not present in WT mice ( Fig. 2 B ) .
It was possible that the Th2 cytokine production by Th1 cells and enhanced IFN-␥ production by Th2 cells from CIITA Tg → B6 and CIITA Tg → CIITA Ϫ / Ϫ BM chimeric mice was caused by CIITA expression rather than thymic selection diff erences. To determine whether CIITA expression itself regulates cytokine gene expression or whether thymic selection is indeed responsible for the phenotype, we tested BM from CIITA Tg /A ␤ Ϫ / Ϫ mice. Cells from CIITA Tg /A ␤ Ϫ / Ϫ mice express the CIITA transgene but not MHC class II because of a defi ciency in the MHC class II structural gene A ␤ . Thus, CIITA Tg /A ␤ Ϫ / Ϫ BM-originated thymocytes in the chimera cannot mediate T-CD4 T cell selection because they do not express MHC class II molecules ( 18, 19 ) . As a consequence, whether IL-4 production by T-CD4 T cells requires Stat6. We have previously observed that CD4 T cells from CIITA Tg mice bred to Stat6 Ϫ / Ϫ mice produced IL-4 ( 29 ) . However, those data did not distinguish whether Stat6 independency is caused by thymic selection. Thus, we tested Stat6 Ϫ / Ϫ CD4 T cells for their ability to produce IL-4 after being selected on thymocytes. For this experiment, we mixed two diff erent sources of BM, as MHC class II -positive thymocytes can mediate the development of MHC class II -negative thymocytes in mixed BM chimeras (unpublished data) ( 18 ) . Stat6 Ϫ / Ϫ BM, together with WT or CIITA Tg (Stat6 ϩ/ϩ ) BM, were cotransferred into B6 or A ␤ Ϫ / Ϫ hosts. To identify diff erent populations of CD4 T cells, we used the congenic marker CD45. Splenic CD4 T cells from reconstituted animals were skewed under Th1-and Th2-polarizing conditions, and Th1 cells derived from Stat6 ϩ/ϩ BM (CD45.2 ϩ ) and Stat6 Ϫ / Ϫ BM (CD45.1 ϩ ) were analyzed for cytokine production by ICS. As expected, Stat6 ϩ/ϩ cells from Stat6 Ϫ / Ϫ ϩ WT → B6 chimeric mice expressed IL-4 when they were diff erentiated to Th2 but not Th1 cells ( Fig. 4 A , top group). When Stat6 Ϫ / Ϫ cells were examined, both Stat6 Ϫ / Ϫ Th1 and Th2 cells from Stat6 Ϫ / Ϫ ϩ WT → B6 BM chimeras produced a negligible amount of IL-4. In contrast, if Stat6 Ϫ / Ϫ were developed in the presence of CIITA Tg BM-derived thymocytes, Stat6 Ϫ / Ϫ Th1 and Th2 CD4 T cells produced IL-4 ( Fig. 4 A , middle and bottom groups). Moreover, Stat6 Ϫ / Ϫ CD4 T cells that were exclusively selected on thymocytes (Stat6 Ϫ / Ϫ ϩ CIITA Tg → A ␤ Ϫ / Ϫ ) had a greater potential to express IL-4. Stat6 ϩ/ϩ cells made IL-4 after diff erentiation into either the Th1 or Th2 cell lineage when they were from both Stat6 Ϫ / Ϫ ϩ CIITA Tg → B6 and Stat6 Ϫ / Ϫ ϩ CIITA Tg → A ␤ Ϫ / Ϫ hosts. The Th2 cell cultures generated more IL-4 -expressing cells than the Th1 cells ( Fig. 4 A ) . We also examined cytokine production by freshly cannot restore the APC function of TECs at full capacity, whereas the same transgene expression in A ␤ Ϫ / Ϫ TECs can. Likewise, thymocytes expressing CIITA would be more efficient APCs than those expressing I-E only. Together with the diff erent phenotype of I-E Tg mice on the A ␤ Ϫ / Ϫ or CIITA Ϫ / Ϫ background, it appears that the potency of antigen presentation of thymocytes and TECs dictates the direction of CD4 T cell selection toward the T-or E-CD4 T cell lineage.
To address this hypothesis, we constructed and tested several additional BM chimeras. The expression pattern of MHC class II, Ii, and H-2M in TECs and thymocytes in mice used in those experiments is shown in the Table S1 (available at http://www.jem.org/cgi/content/full/jem.20070321/DC1). As summarized in Table I , the results showed that if the predicted potency of thymocytes being APCs is greater than
or equivalent to that of TECs (CIITA Tg , I-E Tg /CIITA Ϫ / Ϫ , and CIITA Tg → B6), CD4 T cells seem to be selected on thymocytes as effi ciently as TECs, and the resulting CD4 T cells can express Th2 cytokines under Th1-inducing conditions. In contrast, CD4 T cells did not show the same phenotype when they were developed in mice in which TECs have a greater potential to present antigens than thymocytes (B6, I-E Tg , I-E Tg /A ␤ Ϫ / Ϫ , CIITA Tg /A ␤ Ϫ / Ϫ → B6, I-E Tg → B6, and I-E Tg / CIITA Ϫ / Ϫ → B6). Therefore, these data clearly demonstrate a strong correlation between thymocyte-mediated selection and the Th cell function of the resulting CD4 T cells.
Thymocyte-mediated selection pathway can override a requirement of Stat6 in Th2 cytokine expression NKT cells that are selected on thymocytes produce IL-4 in a Stat6-independent manner ( 36, 37 ) . Therefore, we asked 
Mice indicated with → are BM chimeras. Cells expressing MHC class II, Ii, and H-2M are considered hypothetically more potent than the cells expressing MHC class II in the absence or in low levels of Ii and H-2M. Expression denoted with Ϫ includes cells that express none or a low level of the indicated molecules. ϭ or Ͼ show an equivalent or a stronger potency of antigen presentation function, respectively. Th2 cytokine production was experimentally determined using ICS. N, no; Y, yes.
purifi ed splenic CD4 T cells from Stat6 Ϫ / Ϫ mice were mixed in vitro with WT or CIITA Tg CD4 T cells and diff erentiated under Th1-and Th2-inducing conditions. Stat6 ϩ/ϩ cells showed the expected cytokine profi le from both WT and CIITA Tg Th1 and Th2 cells ( Fig. 4 B ) . However, Stat6 Ϫ / Ϫ CD4 T cells that were codiff erentiated with CIITA Tg CD4 T cells did not acquire the ability to express IL-4. ( Fig. 4 B ) . Collectively, our data strongly suggest that T-CD4 T cells produce Th2 cytokines in a Stat6-independent manner. crease in H3 acetylation ( Fig. 6 A , bottom) . Moreover, this small change correlated with IL-4 gene transcription even in the absence of stimulation, as the amount of IL-4 transcripts was greater in freshly isolated CIITA Tg CD4 SP cells than in control cells ( Fig. 6 B ) . The level of IFN-␥ mRNA in those CIITA Tg thymocytes was variable and did not show a consistent increase (unpublished data). Consistent with the RNA data, NK1.1 Ϫ CD4 SP cells produced a small but reproducibly higher percentage of IL-4 -expressing cells in CIITA Tg and CIITA Tg /CIITA Ϫ / Ϫ but not WT mice ( Fig. 6 C ) . The IL-4 producers were all CD44 hi , which is similar to IL-4 -producing thymic NKT cells (unpublished data). We also examined Stat6 Ϫ / Ϫ thymocytes prepared from mixed BM chimeric mice and found that Stat6 Ϫ / Ϫ thymocytes produced IL-4 when they were selected on thymocytes (Fig. S5 A) . Collectively, our results indicate that the IL-4 locus in CD4 T cells that are selected on thymocytes is programmed for increased expression before Th cell diff erentiation.
T-CD4 T cells can dampen allergen-induced airway infl ammation
To investigate what role T-CD4 T cells play during an immune response in vivo, we used an antigen-induced airway infl ammation model of asthma. CIITA Tg and WT mice were sensitized with chicken OVA and subsequently challenged with aerosolized OVA to induce infl ammation in the respiratory tract. Mice were then killed to measure several parameters that are indicative of airway infl ammation. We fi rst examined the number of total cells in the bronchoalveolar lavage fl uid (BALF). As shown in Fig. 7 A , the total cell numbers in BALF from OVA-challenged mice were decreased in CIITA Tg mice. Infi ltration of eosinophils in the lung tissue is one of the cardinal features of asthma and serves as a simple readout for airway infl ammation. In agreement with the total BALF cell numbers, CIITA Tg mice had signifi cantly fewer BALF eosinophils than WT mice ( Fig. 7 B ) . Neutrophilic infi ltration in BALF was also reduced in CIITA Tg mice ( Fig. 7 B ) . The percentage
NKT cells do not infl uence the phenotype of T-CD4 T cells
The rapid production of IFN-␥ and IL-4, the Th0-like phenotype of T-CD4 cells, and the Stat6-independent IL-4 production by T-CD4 cells seem to be similar to that of NKT cells ( 36, 37 ) . NKT cells play an important role in regulating both innate and adaptive immune responses through their prompt production of large amounts of cytokines, including IL-4 upon both in vivo and in vitro TCR stimulation. Therefore, we investigated whether NKT cells contribute to IL-4 expression in T-CD4 T cells using CIITA Tg mice lacking CD1d (CIITA Tg / CD1d Ϫ / Ϫ ), which is necessary for NKT cell development ( 38 ) . Primarily, when in vivo cytokine production was analyzed, a lack of CD1d and thus a defi ciency in NKT cells did not alter the ability of CIITA Tg mice to produce IL-4 in response to short in vivo stimulation ( Fig. 5 A ) . In addition, CD1d deficiency did not compromise the IL-4 production by CIITA Tg Th1 cells, thymocytes, and peripheral CD4 T cells upon in vitro stimulation ( Fig. 5 B and not depicted) . Therefore, CD1d-restricted NKT cells do not contribute to the Th2 cytokineproducing potential of T-CD4 T cells.
Preformed IL-4 mRNA in T-CD4 cells IL-4 expression in freshly isolated CIITA Tg CD4 T cells (Fig.  S5 ) ( 29 ) suggested that the chromatin structure at the IL-4 locus might already be diff erentially modifi ed. To test this, we performed a chromatin immunoprecipitation (ChIP) assay to analyze the acetylation status of histone H3 at the IL-4 intronic enhancer (IE) that has been shown to be hyperacetylated in diff erentiated Th2 cells ( 39 -41 ) . Naive CD4 T cells were purifi ed from total peripheral CD4 cells obtained from WT and CIITA Tg mice by FACS sorting and subjected to the ChIP assay. In naive CD4 T cells, histone H3 at this regulatory region was indeed hyperacetylated compared with the WT cells ( Fig. 6 A , top) . The modifi ed IL-4 locus in naive cells raised the possibility that a similar change might have occurred in the thymus. Indeed, purifi ed CD4 SP thymocytes from CIITA Tg mice showed a small but consistent in- Currently, it is not known how the thymic selection process regulates Th cell fate. Many factors are known to infl uence Th cell diff erentiation of conventional CD4 T cells, and the IL-4 -Stat6 signaling pathway is critical for the diff erentiation of Th2 eff ector cells ( 14 -17, 42 -44 ) . Stat6 activates GATA3, the master regulator of Th2 cells, which subsequently mediates chromatin remodeling accompanied by an increased level of histone hyperacetylation at the IL-4 locus. Although we could detect enhanced histone H3 and H4 acetylation at the IL-4 IE in both CD4 SP thymocytes and naive CD4 T cells from CIITA Tg mice, we found little diff erence in GATA3 expression in CIITA Tg cells as compared with WT controls (unpublished data). Consistent with this fi nding, we showed that Th2 cytokine production by T-CD4 T cells does not totally depend on the Stat6 signaling pathway. Interestingly, this Stat6-independent production of IL-4 is shared by NKT cells ( 36, 37 ) . NKT cells coexpress surface markers characteristic of both conventional T cells and NK cells and are positively selected by nonclassic MHC class I molecule CD1d on cortical double-positive thymocytes ( 45 -47 ) . Functionally, NKT cells resemble innate effector cells in that they promptly produce large amounts of of monocytes was signifi cantly higher in CIITA Tg than in WT mice, whereas the level of lymphocytes was comparable between WT and CIITA Tg mice ( Fig. 7 B ). Hematoxylin and eosin (H & E) staining of lung tissue sections also supported the diff erence in eosinophil infi ltration between the two groups of mice ( Fig. 7 C ) . In addition, OVA-specifi c IgE levels in serum were decreased in CIITA Tg mice ( Fig. 7 D ) . We further examined the expression of several cytokines involved in airway infl ammation. The lung tissue from OVA-sensitized and -challenged CIITA Tg mice had signifi cantly more IFN-␥ but less IL-13 and IL-17 transcripts compared with the WT control mice. The IL-4 and IL-5 mRNA levels were comparable between the two groups ( Fig. 7 E ) . Collectively, T-CD4 T cells seem to play a protective role during airway infl ammation, which was associated with a distinct Th eff ector cytokine production profi le at the site of infl ammation.
DISCUSSION
In this study, we have shown that the thymic selection process plays an important role in the cytokine production potential of CD4 T cells. Hence, unlike E-CD4 T cells, T-CD4 T cells secrete both Th1 and Th2 cytokines shortly after stimulation. Remarkably, IL-4 -producing cells can develop in the absence of Stat6 when CD4 T cells are selected on thymocytes. In addition, T-CD4 T cells can produce IL-5 and IL-13 in the absence of IL-4 ( 29 ). These observations are with Th cell diff erentiation ( 51 -55 ) . Therefore, the diff erence in TCR signaling potency could contribute to Th cytokine production by T-CD4 T cells. Previously, we demonstrated that the antigen repertoire of thymocytes does not totally overlap with that of TECs ( 19 ) . Our current data also showed that the antigen presentation potential of thymic APCs seems to regulate the selection pathway and Th cell fate. Therefore, it appears that developing thymocytes receive diff erent signal strength when they are selected on thymocytes, generating a distinct cellular phenotype of cells. This is consistent with the similar cytokine production potential observed in both T-CD4 T cells and NKT cells.
Despite the fact that T-CD4 cells can readily express Th2 cytokines in vivo, mice that can generate T-CD4 T cytokines such as IFN-␥ and IL-4 cytokines upon TCR stimulation. It was shown that during thymic development, the IFN-␥ and IL-4 loci in NKT cells are modifi ed by histone acetylation and both genes are constitutively transcribed, which correlates well with the capacity of NKT cells to rapidly produce cytokines ( 37 ) . However, T-CD4 T cells are distinct from NKT cells ( 19 ) , and their phenotype is not infl uenced by CD1d-restricted NKT cells.
T cells selected on thymocytes such as NKT cells and nonclassical MHC class Ib -restricted CD8 cells appear to have TCR with higher avidity ( 48 -50 ) . Similarly, it is possible that thymocytes with higher TCR avidity could have been preferentially selected on MHC class II -positive thymocytes. The TCR signaling potency is known to be associated Perhaps the presence of two selection pathways in humans is responsible for generating CD4 T cells that produce both IL-4 and IFN-␥ . Further investigations are warranted to elucidate the role of T-CD4 T cells in the modulation of immune diseases in humans.
MATERIALS AND METHODS
Mice.
Mice carrying the human type III CIITA transgene (CIITA Tg ), CIITA-defi cient mice (CIITA Ϫ / Ϫ ), CIITA Tg mice on the CIITA-defi cient background (CIITA Tg /CIITA Ϫ / Ϫ ) and on the MHC class II -defi cient A ␤ Ϫ / Ϫ background (CIITA Tg /A ␤ Ϫ / Ϫ ), MHC class II I-E transgenic mice (I-E Tg ), I-E Tg mice on the CIITA-defi cient background (I-E Tg /CIITA Ϫ / Ϫ ) and on the MHC class II -defi cient A ␤ Ϫ / Ϫ background (I-E Tg /A ␤ Ϫ / Ϫ ), and Stat6 Ϫ / Ϫ mice were previously described ( 19, 29, 32, 34, 44 ) . CD1d-deficient mice on the C57BL/6 background ( 38 ) were bred with CIITA Tg mice to generate CIITA Tg /CD1d Ϫ / Ϫ mice, and WT and CIITA Tg /CD1d ϩ/ Ϫ littermates were used as CD1d-positive controls. Stat6 Ϫ / Ϫ mice were bred onto the H-2 b background and carried the CD45.1 congenic marker. C57BL/6 (B6) mice and the MHC class II -defi cient A ␤ Ϫ / Ϫ mice were purchased from the Jackson Laboratory and Taconic, respectively, and bred in the animal facility at the Indiana University School of Medicine (IUSM). All mice were housed under specifi c pathogen-free conditions and used at 6 -12 wk of age. All animal experiments were performed under protocols approved by the IUSM Animal Care and Use Committee.
In vivo anti-CD3 stimulation. PBS or 10 μ g anti-CD3 antibody in PBS was injected into WT or CIITA Tg mice through the tail vein. 2 h later, mice were killed and blood was collected by cardiac puncture. Serum cytokines were determined by ELISA.
BM chimeras. Recipient B6, A ␤ Ϫ / Ϫ , or CIITA Ϫ / Ϫ mice were lethally irradiated (950 rad) and rested for 24 h before receiving BM cells. Total BM cells were prepared from the femurs and tibias of donor mice (2 -3 mo of age) and depleted of mature T cells, B cells, and MHC class II -positive lymphocytes by using a cocktail of antibodies containing anti-CD4 (RL172) and anti-CD8 (TIB105, TIB210), anti-CD19 (1D3), and anti -MHC class II (M5/114), followed by complement-mediated lysis. These cells were subsequently referred to as T-depleted BM cells. Each recipient mouse received 2.5 × 10 6 T-depleted BM cells in 500 μ l of 1 × PBS via tail vein injection. Reconstituted mice were analyzed 2 -3 mo later.
Flow cytometry. All antibodies for fl ow cytometry were purchased from BD Biosciences, and cells were preincubated with the anti-Fc ␥ R mAb 2.4G2 to block nonspecifi c antibody binding. The following FITC-, PE-, PerCP-, cychrome-, allophycocyanin-, or biotin-conjugated antibodies were used: CD4 (L3T4), CD8 (53-6.7), CD45RB (16A), CD44 (IM7), NK1.1 (PK136), CD1d (1B1), CD45.1 (A20), CD45.2 (104), anti -IL-4 (11B11), and anti -IFN-␥ (XMG1.2). Allophycocyanin-conjugated streptavidin was used to visualize staining by biotinylated primary antibodies. Events were acquired on a fl ow cytometer (FACSCalibur; Beckman Dickinson), and the data were analyzed using CellQuest software (BD Biosciences).
T cell preparation and stimulation. To purify CD4 and CD8 SP T cells, total thymocytes were depleted of double-positive cells by complementmediated lysis of HSA ϩ cells. The remaining cells were subsequently sorted electronically for NK1.1 Ϫ CD4 ϩ CD8 Ϫ and NK1.1 Ϫ CD4 Ϫ CD8 ϩ cells. Total peripheral CD4 cells were enriched from single-cell suspensions from spleen and lymph nodes (auxiliary, brachial, inguinal, and mesenteric) with antimouse CD4 microbeads (Miltenyi Biotec). To obtain naive CD4 T cells, enriched CD4 T cells were stained with anti-CD4, CD45RB, and CD44 and electronically sorted for CD4 ϩ CD45RB hi CD44 lo cells. In some experiments, CD4 T cells were enriched from splenocytes. To induce Th cell differentiation under neutral conditions (ThN), total peripheral, splenic CD4 T cells or 10 6 naive T cells/ml were stimulated with 5 g/ml of plate-bound cells were less susceptible to airway infl ammation induced by a Th2-biased allergen. Although it is not yet clear how T-CD4 T cells exert this suppressive eff ect, several possibilities can be envisioned. First, T-CD4 T cells can produce IFN-␥ at a high level upon stimulation. Because IFN-␥ has been shown to suppress the development of mouse airway infl ammation ( 56, 57 ) , it is possible that the IFN-␥ produced by T-CD4 T cells can dampen Th2-inducing conditions in vivo, which in turn may attenuate the function of Th2 cells during disease development. Second, there was a marked reduction of IL-17 transcripts in the lung tissue of the OVA-challenged CIITA Tg mice. IL-17 has been shown to play an important role in many immune diseases, including airway infl ammation ( 3, 58, 59 ) . Because both IL-4 and IFN-␥ suppress the generation of Th17 ( 2, 3 ), T-CD4 T cells with a dual cytokine production potential might have altered Th17 cell diff erentiation, contributing to protection. Indeed, CIITA Tg CD4 T cells make substantially less IL-17 than WT CD4 T cells in vitro (unpublished data). Reduced IL-17 production in CIITA Tg mice could also be responsible for protecting them from experimental auto immune encephalomyelitis ( 60 ) . Third, T-CD4 T cells may have a limited capability to expand during the challenge period, and mount an ineffi cient memory response. In this regard, nonclassical MHC class Ib -restricted CD8 cells that can be selected on TECs or hematopoietic cells failed to undergo secondary expansion upon Listeria infection, even though they can mount a rapid primary immune response ( 50, 61 -63 ) . Lastly, it is possible that OVA-specifi c eff ector T-CD4 T cells could not be generated effi ciently or their infi ltration into the lung was defective. An identifi cation of markers specifi c for T-CD4 T cells would help to address this issue in the future. Regardless of mechanism, T-CD4 T cells appear to play a critical and diverse role during an immune response.
A substantial portion of human fetal and neonatal thymocytes express MHC class II molecules, which have been shown to be involved in the positive selection of CD4 T cells through interactions between thymocytes ( 64 ). Therefore, it is reasonable to propose that healthy individuals have two CD4 T cell populations selected on TECs as well as thymocytes. At the moment, nothing is known about the regulation of these two pathways. We do not know whether the two populations of CD4 T cells are selected and maintained equally or whether one population is preferentially selected over the other. Nonetheless, it is conceivable that the diff erential selection effi ciency in an individual could have profound consequences in immunity. Whereas Th cell diff erentiation is relatively easy to observe in mice, the paradigm has not been as clear in the human system ( 65 -70 ) . In addition, diff erentiated human Th cells can produce both cytokines when they are cultured in the opposing polarizing condition ( 71 ), whereas committed mouse Th cells cannot be reversed ( 72 ) . The phenotype of human Th cells suggests a distinct genetic programming in their cytokine gene expression, which appears to be similar to T-CD4 T cells in CIITA Tg mice.
Online supplemental material. Table S1 shows MHC class II, Ii, and H-2M expression in mice used in this study. Fig. S1 shows MHC class II expression on thymocytes and CD44 and CD45RB expression on splenic CD4 T cells from WT, CIITA Tg , CIITA Tg /CIITA Ϫ / Ϫ , and I-E Tg mice. Fig. S2 shows the gate used to sort naive CD4 T cells (CD45RB hi CD44 lo ). Fig. S3 shows IL-4 and IFN-␥ production by Th1 and Th2 cells diff erentiated from total WT, CIITA Tg , and CIITA Tg /CIITA Ϫ / Ϫ CD4 T cells. Fig. S4 shows the generation of E-and T-CD4 T cells in BM chimeric mice. The FACS plots represent profi les of CD4 versus CD8 in the thymus and LN. Fig. S5 shows IL-4 production by TEC-and thymocyte-selected Stat6 Ϫ / Ϫ thymocytes and splenic CD4 T cells from chimeras that were reconstituted with Stat6 Ϫ / Ϫ and WT or CIITA Tg BM. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20070321/DC1.
Cytokine assays. For the ELISA assays, diff erentiated cells were restimulated overnight with 5 g/ml of plate-bound anti-CD3 antibody at a cell density of 1 ϫ 10 6 /ml. IL-4 and IFN-␥ in the supernatants were quantifi ed by paired cytokine-specifi c antibodies (BD Biosciences). Recombinant cytokines were used as standards. For ICS, cells were stimulated with 50 ng/ml phorbol myristyl acetate and 1.5 M ionomycin (Calbiochem) for 5 h. Monensin (Sigma-Aldrich) at 3 M was added during the last 3 h of stimulation. Activated cells were stained with anti-CD4 and anti-NK1.1 in some cases. Cells were fi xed in 2 -4% paraformaldehyde and permeabilized with 0.2% saponin (Sigma-Aldrich), followed by staining with anti-IL4 (11B11) and anti -IFN-␥ (XMG1.2) for fl ow cytometry.
RT-PCR.
Total RNA was extracted from sorted CD4 SP thymocytes lysed in TRI zol reagent (Invitrogen), according to the manufacturer ' s recommendations, and reverse transcribed using the SuperScript First-Strand cDNA Synthesis System (Invitrogen). Quantitative real-time PCR was performed with SYBR Green PCR Master Mix (Applied Biosystems). All PCR reactions were done in triplicate, and the data were analyzed by the comparative threshold cycle ( ⌬ C T ) method and normalized to GAPDH. The primer pairs used for GAPDH were 5 Ј -CCAGGTTGTCTCCTGCGACT-3 Ј and 5 Ј -ATAC-CAGGAAATGAGCTTGACAAAGT-3 Ј , and for IL-4 were 5 Ј -ACAG-GAGAAGGGACGCCAT-3 Ј and 5 Ј -GAAGCCCTACAGACGAGCTCA-3 Ј ( 73 ). Message levels of IFN-␥ , IL-4, IL-5, IL-13, and IL-17A in the lung tissue were analyzed by TaqMan PCR (all reagents were obtained from Applied Biosystems). Cycle number of duplicate samples was normalized to expression of ␤ 2-microglobulin. Results are relative to one of the WT mice.
ChIP analysis. ChIP analysis was performed according to the ChIP assay protocol (Upstate Biotechnology). In brief, 2 -3 ϫ 10 6 sorted CD4 or CD8 SP thymocytes or sorted naive CD4 cells from WT and CIITA Tg mice were fi xed in 1% formaldehyde for 10 min at room temperature, washed, lysed, and sonicated with three pulses to generate chromatin fragments of ‫ف‬ 500-bp in length. Antiacetylated histone H3 antibody (Upstate Biotechnology) was added (3 l per immunoprecipitation) to the diluted lysates and incubated overnight. No antibody group was used as a negative control. Protein Asepharose CL-4B beads (GE Healthcare) were added for 1 h. After washes, the immunocomplexes were eluted, the cross-links were reversed, and DNA was purifi ed by phenol/chloroform extraction and resuspended in 50 l TE buff er. Semiquantitative PCR was done with twofold serial dilutions of ChIP DNA samples. The primers used for IL-4 IE were 5 Ј -GGGTGT-GAATAAGCCATATTG-3 Ј and 5 Ј -CCCAGCGTTTACATGAGC-3 Ј ( 40 ), and for CD3 were 5 Ј -CATTTCCAAGTGACGTGG-3 Ј and 5 Ј -AACA-CACTGGCTGCATGC-3 Ј ( 39 ).
OVA-induced airway infl ammation. On days 0 and 7, mice were sensitized i.p. with 20 μ g OVA (grade V; Sigma-Aldrich) adsorbed onto 0.5 mg of aluminum hydroxide gel (Sigma-Aldrich) in 0.5 ml PBS. Beginning on day 14, mice were challenged with aerosolized OVA from a 1% OVA/PBS solution for 20 min using a jet nebulizer for 7 consecutive days. 2 d after the last aerosol challenge, mice were anesthetized with sodium pentobarbital. BALF was collected from airways by three washes with 1 ϫ PBS. After BALF collection, blood was drawn by a cardiac puncture, and a portion of the lung was fi xed in 10% buff ered formalin for histological examination. The remaining lung tissue was stored in RNAlater solution (Ambion) and homogenized in TRI zol for RNA preparation. After cytospin of the BALF, slides were stained with the Diff -Quick stain set (Baxter), and diff erential cell numbers were determined by counting 200 cells per slide. OVA-specifi c IgE levels in serum were measured by ELISA, and the data were expressed as OD readings. Fixed lung tissues were embedded in paraffi n, cut into 5-m-thick sections, and stained with H & E for histological analysis of airway infl ammation.
